Now Is the Time to Use FDG-PET/CT to Optimize Neoadjuvant Treatment in Triple Negative Breast Cancer!

Journal of Nuclear Medicine - China
doi 10.2967/jnumed.118.210922
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Society of Nuclear Medicine

Related search

Identification of Biomarkers Including 18fdg-Pet/Ct for Early Prediction of Response to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer

Clinical Cancer Research
Cancer ResearchOncology
2015English

[18f]ml-10 PET Imaging Fails to Assess Early Response to Neoadjuvant Chemotherapy in a Preclinical Model of Triple Negative Breast Cancer

EJNMMI Research
Nuclear MedicineRadiologyImaging
2020English

18f-Fluorodeoxyglucose (FDG) PET/CT After Two Cycles of Neoadjuvant Therapy May Predict Response in HER2-negative, but Not in HER2-positive Breast Cancer

Oncotarget
Oncology
2015English

Early Metabolic Response Using FDG PET/CT and Molecular Phenotypes of Breast Cancer Treated With Neoadjuvant Chemotherapy

BMC Cancer
Cancer ResearchOncologyGenetics
2011English

Targeted-Gene Sequencing to Catch Triple Negative Breast Cancer Heterogeneity Before and After Neoadjuvant Chemotherapy

Cancers
Cancer ResearchOncology
2019English

A Comparison of Near-Infrared Diffuse Optical Imaging and 18f-FDG PET/CT for the Early Prediction of Breast Cancer Response to Neoadjuvant Chemotherapy

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2016English

The Time Is Now: Model-Based Dosing to Optimize Drug Therapy

International Journal of Pharmacokinetics
2017English

Effectiveness of 18f-FDG PET/CT in Detection of Loco-Regional Recurrence of Breast Cancer in Comparison to CT Alone

Sohag Medical Journal
2019English

Predicting Response to Neoadjuvant Chemoradiotherapy in Esophageal Cancer With Textural Features Derived From Pretreatment 18 F-FDG PET/CT Imaging

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy